PREDICTION OF INDIVIDUALIZED TREATMENT IN CHILDREN WITH DRUG-RESISTANT EPILEPSY BASED ON CLINICAL, GENETIC AND NEUROIMMUNOLOGICAL PREDICTORS USING ARTIFICIAL INTELLIGENCE

Authors
  • G.R.Vafoeva

    Author

Keywords:
Array
Abstract

Drug-resistant epilepsy (DRE) in children represents one of the most challenging conditions in pediatric neurology, characterized by persistent seizures despite appropriate antiseizure treatment and a high risk of cognitive, neurodevelopmental, and functional impairment. The aim of this study is to identify clinical, genetic, and neuroimmunological predictors of drug-resistant epilepsy in children and to develop an artificial intelligence-based approach for predicting individualized treatment response. The study will include children with epilepsy with assessment of clinical and neurological characteristics, seizure type and frequency, age at seizure onset, neurodevelopmental status, EEG and MRI findings, genetic variants, and neuroimmunological biomarkers. Clinical, genetic, neuroimmunological, and instrumental parameters will be analyzed using statistical and machine-learning methods. The prognostic significance of individual and combined predictors for drug resistance and treatment response will be determined. Based on the obtained results, an artificial intelligence-based predictive model will be developed to support individualized treatment prognosis in children with epilepsy. The proposed approach is expected to facilitate early identification of children at high risk of drug-resistant epilepsy, improve prediction of treatment response, and contribute to the optimization of individualized therapeutic strategies.

References

Scheffer I.E., Berkovic S., Capovilla G., et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512–521. https://doi.org/10.1111/epi.13709

Berg A.T., Berkovic S.F., Brodie M.J., et al. Revised terminology and concepts for organization of seizures and epilepsies. Epilepsia. 2010;51(4):676–685. https://doi.org/10.1111/j.1528-1167.2010.02522.x

Specchio N., Curatolo P. Developmental and epileptic encephalopathies: What we do and do not know. Brain. 2021;144(1):32–43. https://doi.org/10.1093/brain/awaa371

Vezzani A., Balosso S., Ravizza T. Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nature Reviews Neurology. 2019;15(8):459–472. https://doi.org/10.1038/s41582-019-0217-x

Ravizza T., Gagliardi B., Noé F., et al. Innate and adaptive immunity during epileptogenesis and spontaneous seizures. Epilepsia. 2019;60(3):407–421. https://doi.org/10.1111/epi.14669

Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nature Reviews Neurology. 2011;7(1):31–40. https://doi.org/10.1038/nrneurol.2010.178

Kwon C.S., Wagner R.G., Carpio A., et al. The worldwide epidemiology of epilepsy: A systematic review. Epilepsia. 2022;63(2):273–285. https://doi.org/10.1111/epi.17125

Zuberi S.M., Wirrell E., Yozawitz E., et al. ILAE classification and definition of epilepsy syndromes with onset in childhood. Epilepsia. 2022;63(6):1349–1397. https://doi.org/10.1111/epi.17241

Baram T.Z., Hatalski C.G. Neuronal excitability and seizure susceptibility: Inflammatory mechanisms. Trends in Neurosciences. 1998;21(12): 531–535. https://doi.org/10.1016/S0166-2236(98)01300-0

Aronica E., Crino P.B. Inflammation in epilepsy: Clinical observations. Epilepsia. 2011;52(Suppl 3):26–32. https://doi.org/10.1111/j.1528-1167.2011.03033.x

Klein P., Dingledine R., Aronica E., et al. Commonalities in epileptogenic processes from different acute brain insults. Epilepsia. 2018;59(1):37–66. https://doi.org/10.1111/epi.13965

Rana A., Musto A.E. The role of inflammation in the development of epilepsy. Journal of Neuroinflammation. 2018;15:144. https://doi.org/10.1186/s12974-018-1192-7

Vezzani A., Lang B., Aronica E. Immunity and inflammation in epilepsy. Cold Spring Harbor Perspectives in Medicine. 2016;6(2):a022699. https://doi.org/10.1101/cshperspect.a022699

Singhi P., Sahu J.K., Vyas S., et al. Biomarkers in childhood epileptic encephalopathies. Indian Journal of Pediatrics. 2014;81(11):1141–1148. https://doi.org/10.1007/s12098-014-1525-6

Pardo C.A., Vargas D.L., Zimmerman A.W. Immunity, neuroglia and neuroinflammation in epilepsy. Journal of Neuroimmunology. 2005; 165(1–2):3–14. https://doi.org/10.1016/j.jneuroim.2005.02.011

Cover Image
Downloads
Published
2026-10-06
Section
Articles